篮球赔率

篮球赔率 Services FAQ Contact Us 0
Home Biotechnology Metabolomics Market Size, Share, Growth & Demand Report by 2033
Metabolomics Market

Metabolomics Market Size, Share & Trends Analysis Report By Metabolite Analysis (Analytical Techniques, Detection Techniques, Bioinformatics Tools and Databases), By Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Other Applications), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Others), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI1209DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Metabolomics Market Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Metabolite Analysis
        1. Introduction
          1. Metabolite Analysis By Value
        2. Analytical Techniques
          1. By Value
        3. Detection Techniques
          1. By Value
        4. Bioinformatics Tools and Databases
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Biomarker and Drug Discovery
          1. By Value
        3. Toxicology
          1. By Value
        4. Nutrigenomics
          1. By Value
        5. Personalized Medicine
          1. By Value
        6. Other Applications
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Inborn Errors of Metabolism
          1. By Value
        6. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical and Biotechnology Companies
          1. By Value
        4. Contract Research Organizations
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Metabolite Analysis
        1. Introduction
          1. Metabolite Analysis By Value
        2. Analytical Techniques
          1. By Value
        3. Detection Techniques
          1. By Value
        4. Bioinformatics Tools and Databases
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Biomarker and Drug Discovery
          1. By Value
        3. Toxicology
          1. By Value
        4. Nutrigenomics
          1. By Value
        5. Personalized Medicine
          1. By Value
        6. Other Applications
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Inborn Errors of Metabolism
          1. By Value
        6. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical and Biotechnology Companies
          1. By Value
        4. Contract Research Organizations
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Metabolite Analysis
        1. Introduction
          1. Metabolite Analysis By Value
        2. Analytical Techniques
          1. By Value
        3. Detection Techniques
          1. By Value
        4. Bioinformatics Tools and Databases
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Biomarker and Drug Discovery
          1. By Value
        3. Toxicology
          1. By Value
        4. Nutrigenomics
          1. By Value
        5. Personalized Medicine
          1. By Value
        6. Other Applications
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Inborn Errors of Metabolism
          1. By Value
        6. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical and Biotechnology Companies
          1. By Value
        4. Contract Research Organizations
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Metabolite Analysis
        1. Introduction
          1. Metabolite Analysis By Value
        2. Analytical Techniques
          1. By Value
        3. Detection Techniques
          1. By Value
        4. Bioinformatics Tools and Databases
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Biomarker and Drug Discovery
          1. By Value
        3. Toxicology
          1. By Value
        4. Nutrigenomics
          1. By Value
        5. Personalized Medicine
          1. By Value
        6. Other Applications
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Inborn Errors of Metabolism
          1. By Value
        6. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical and Biotechnology Companies
          1. By Value
        4. Contract Research Organizations
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Metabolite Analysis
      1. Introduction
        1. Metabolite Analysis By Value
      2. Analytical Techniques
        1. By Value
      3. Detection Techniques
        1. By Value
      4. Bioinformatics Tools and Databases
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Biomarker and Drug Discovery
        1. By Value
      3. Toxicology
        1. By Value
      4. Nutrigenomics
        1. By Value
      5. Personalized Medicine
        1. By Value
      6. Other Applications
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Cancer
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Inborn Errors of Metabolism
        1. By Value
      6. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical and Biotechnology Companies
        1. By Value
      4. Contract Research Organizations
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Metabolite Analysis
        1. Introduction
          1. Metabolite Analysis By Value
        2. Analytical Techniques
          1. By Value
        3. Detection Techniques
          1. By Value
        4. Bioinformatics Tools and Databases
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Biomarker and Drug Discovery
          1. By Value
        3. Toxicology
          1. By Value
        4. Nutrigenomics
          1. By Value
        5. Personalized Medicine
          1. By Value
        6. Other Applications
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Cancer
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Inborn Errors of Metabolism
          1. By Value
        6. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical and Biotechnology Companies
          1. By Value
        4. Contract Research Organizations
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Metabolomics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Agilent Technologies INC.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BiocratesLife Science AG
    3. Bio-Rad Laboratories INC.
    4. Bruker corporation
    5. Danaher Corporation
    6. Human Metabolome Technologies INC.
    7. LECO Corporation
    8. Metabolon INC.
    9. Shimadzu Corporation
    10. Water Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Metabolic Testing Market Size The global metabolic testing market size was valued at USD 547.32 million in 2024 and is projected to grow from USD 589.03 million in 2025 to USD 1,060.82 million by 2033, growing at a CAGR of 7.63% during the fore
Buy Now
Global Report
Metabolomics Market Size The global metabolomics size was valued at USD 2.72 Billion in 2024 and is expected  to grow from USD 3.08 Billion in 2025 to reach USD 8.29 Billion by 2033, exhibiting a CAGR of 13.2% during the forecast period (2025&n
Buy Now
Global Report
The global retinal biologics market was valued at USD 22.89 billion in 2023. It is estimated to reach USD 41.20 billion by 2032, growing at a CAGR of 6.75% during the forecast period (2024–2032). In recent years, a rise in the aging population
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

篮球赔率
漏 Copyright . All rights Reserved.